Sequenom Files $150 Million Shelf Offering (SQNM)

Shares of Sequenom, Inc. SQNM are trading lower in the after-hours by 2.84%, trading at $6.85 after the company reported that it filled a $150 million mixed securities shelf offering. SQNM closed the regular session at $7.05, higher by 0.57%. Sequenom, Inc. is a diagnostic testing and genetics analysis company. The company is focused on providing products, services, diagnostic testing, applications and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock and other areas of research. Its development and commercialization efforts in various diagnostic areas include non-invasive women's health-related and prenatal diagnostics, age-related macular degeneration diagnostics, oncology, infectious diseases, and other disorders and diseases. On February 27, 2009, the Company acquired certain assets of SensiGen, LLC.